Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › RI › Warwick › NPI 1386643294
Physician

Kent County Memorial Hospital

Kent County Memorial Hospital was paid $90.78M by Medicaid between Jan 2018 and Dec 2024, across 316 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 13% of everything it billed.

33Billing provider infoKENT COUNTY MEMORIAL HOSPITAL
WARWICK, RI 02886
33aNPI1386643294assigned 07/21/2005
33bProvider typeCardiovascular Disease Physician
28Total paid$90.78M
24GClaims733,532
24DCodes billed316
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Cardiovascular Disease Physician providers in Rhode Island

Rank by total paid#1 of 65
Median peer was paid$19K
This provider vs. median4,676×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018151,530$15.25M
2019180,711$20.88M
202073,199$9.31M
202171,020$8.30M
202286,150$11.84M
2023103,245$15.99M
2024incomplete67,677$9.22M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 13% 67,320 48,088 $11.83M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.9% 9,838 7,870 $6.23M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6.6% 32,860 8,093 $6.02M
G0378 Hospital observation service, per hour 4.7% 3,687 2,815 $4.25M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.6% 11,412 9,504 $4.20M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 3.0% 10,596 8,746 $2.74M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3.0% 35,495 25,818 $2.70M
80048 Basic metabolic panel (calcium, ionized) 2.3% 24,135 17,749 $2.10M
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.6% 16,724 6,416 $1.47M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 15,067 11,335 $1.43M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.5% 4,635 3,878 $1.35M
80053 Comprehensive metabolic panel 1.3% 14,252 11,660 $1.18M
304 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 6,841 $1.13M
96375 Therapeutic injection; each additional sequential IV push 1.2% 5,731 $1.11M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.2% 6,266 $1.06M
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.1% 10,894 $1.01M
J7030 Infusion, normal saline solution , 1000 cc 1.1% 4,948 $961K
J2405 Injection, ondansetron hydrochloride, per 1 mg 1.0% 3,608 $953K
84484 1.0% 7,349 $913K
83735 <1% 10,082 $899K
83036 Hemoglobin; glycosylated (A1C) <1% 11,990 $893K
80061 Lipid panel <1% 11,899 $872K
82962 <1% 6,935 $872K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 13,917 $870K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,865 $750K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,392 $728K
80076 <1% 7,092 $683K
71045 Radiologic examination, chest; single view <1% 3,952 $654K
84443 Thyroid stimulating hormone (TSH) <1% 10,327 $652K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,136 $596K
85610 <1% 9,044 $591K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 2,785 $589K
81001 <1% 9,931 $562K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,575 $560K
83690 <1% 4,413 $541K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,876 $537K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,999 $532K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,903 $522K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,697 $510K
70450 Computed tomography, head or brain; without contrast material <1% 3,227 $496K
84100 <1% 6,040 $489K
36415 Collection of venous blood by venipuncture <1% 6,197 $470K
86803 <1% 4,053 $441K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 2,314 $436K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 19,667 $427K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,517 $420K
J2704 Injection, propofol, 10 mg <1% 1,900 $418K
71046 Radiologic examination, chest; 2 views <1% 5,589 $415K
97161 <1% 3,414 $404K
96376 <1% 2,062 $398K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,288 $383K
83605 <1% 2,621 $381K
20610 <1% 739 $381K
81025 <1% 4,482 $345K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,139 $342K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,786 $326K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,357 $324K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,467 $322K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,479 $320K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 6,343 $315K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 5,061 $306K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,588 $303K
82728 <1% 4,534 $298K
86850 <1% 3,872 $294K
82607 <1% 4,453 $282K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,162 $274K
85027 <1% 7,902 $271K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,675 $269K
86900 <1% 3,920 $268K
86901 <1% 3,936 $265K
97116 <1% 1,201 $259K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 4,380 $247K
83550 <1% 4,352 $246K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,308 $246K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,042 $239K
80050 General health panel <1% 3,070 $235K
95806 <1% 907 $229K
81003 <1% 2,612 $226K
93017 <1% 1,297 $219K
85652 <1% 4,063 $211K
83615 <1% 3,651 $205K
84703 <1% 1,416 $202K
87340 <1% 2,305 $201K
72125 Computed tomography, cervical spine; without contrast material <1% 1,433 $196K
J1644 Injection, heparin sodium, per 1000 units <1% 910 $192K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,226 $187K
82565 <1% 3,890 $183K
87088 <1% 3,066 $181K
99219 <1% 64 $178K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,002 $175K
97597 <1% 2,243 $173K
80051 <1% 2,056 $170K
59025 Fetal non-stress test <1% 923 $170K
84439 <1% 2,677 $165K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 18,003 $165K
86140 <1% 2,218 $164K
87040 <1% 1,044 $162K
87186 <1% 2,085 $159K
99213 Doctor's office visit, returning patient (routine) <1% 1,080 $158K
94060 <1% 663 $157K
84520 <1% 2,411 $155K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,998 $154K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,342 $154K
86780 <1% 4,704 $151K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,904 $150K
J1170 Injection, hydromorphone, up to 4 mg <1% 712 $149K
82784 <1% 756 $146K
73560 <1% 1,134 $145K
36416 <1% 475 $144K
87070 <1% 2,072 $134K
93971 <1% 996 $131K
85730 <1% 1,643 $130K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 919 $129K
20611 <1% 167 $125K
82746 <1% 1,966 $124K
87480 <1% 2,052 $123K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 698 $123K
83880 <1% 1,527 $121K
87510 <1% 1,971 $117K
82043 <1% 2,423 $113K
87660 <1% 2,066 $112K
J2060 Injection, lorazepam, 2 mg <1% 743 $112K
97162 <1% 1,119 $111K
76642 <1% 1,083 $108K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 258 $107K
86618 <1% 1,179 $101K
90461 <1% 1,883 $100K
87077 <1% 1,602 $98K
82550 <1% 1,313 $97K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 764 $95K
99220 <1% 31 $94K
94664 <1% 732 $93K
72100 <1% 1,091 $93K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 68 $93K
76830 Ultrasound, transvaginal <1% 458 $90K
73030 <1% 1,131 $89K
84145 <1% 474 $85K
82310 <1% 707 $85K
77066 Tomosynthesis, mammo <1% 529 $84K
71275 Computed tomographic angiography, chest, with contrast material <1% 454 $81K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 432 $76K
94729 <1% 1,805 $72K
86706 <1% 819 $71K
97165 <1% 549 $70K
71250 <1% 434 $67K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 106 $66K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 155 $62K
84702 <1% 874 $60K
97014 <1% 814 $60K
77065 Tomosynthesis, mammo <1% 471 $58K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 262 $57K
76536 <1% 330 $54K
86762 <1% 1,150 $52K
82570 <1% 1,818 $52K
84460 <1% 2,059 $52K
84450 <1% 2,052 $52K
71271 <1% 269 $46K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,015 $43K
85046 <1% 1,040 $43K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 314 $43K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 828 $42K
87205 <1% 469 $41K
82248 <1% 1,103 $40K
73630 <1% 566 $39K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 174 $39K
85379 <1% 450 $39K
A6250 Skin sealants, protectants, moisturizers, ointments, any type, any size <1% 62 $38K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,253 $37K
73130 <1% 317 $36K
73610 <1% 368 $36K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 592 $36K
86704 <1% 264 $35K
99152 <1% 202 $35K
86481 <1% 282 $34K
99214 Doctor's office visit, returning patient (more involved) <1% 431 $33K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 385 $31K
84165 <1% 132 $30K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 106 $30K
84155 <1% 135 $30K
82803 <1% 158 $30K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 87 $29K
J7050 Infusion, normal saline solution, 250 cc <1% 416 $28K
85018 <1% 714 $25K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 127 $24K
86431 <1% 416 $24K
86334 <1% 88 $24K
86141 <1% 386 $23K
87075 <1% 258 $23K
73110 <1% 245 $23K
82947 <1% 942 $23K
J1815 Injection, insulin, per 5 units <1% 204 $22K
73562 <1% 433 $21K
87430 <1% 286 $21K
73565 <1% 665 $21K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 179 $21K
81002 <1% 2,026 $20K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 158 $20K
87581 <1% 109 $20K
J1650 Injection, enoxaparin sodium, 10 mg <1% 69 $20K
93880 <1% 170 $19K
97035 <1% 294 $19K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 169 $18K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 253 $18K
94010 <1% 231 $18K
86787 <1% 244 $18K
83001 <1% 270 $18K
94727 <1% 471 $17K
97535 Self-care/home management training, each 15 minutes <1% 248 $16K
J3475 Injection, magnesium sulfate, per 500 mg <1% 215 $16K
88307 <1% 222 $16K
84481 <1% 271 $16K
88304 <1% 117 $16K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 151 $16K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 157 $15K
84550 <1% 496 $15K
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 38 $15K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 226 $15K
85014 <1% 376 $15K
94799 <1% 57 $15K
87081 <1% 552 $14K
90715 <1% 121 $14K
87147 <1% 75 $13K
93970 <1% 120 $13K
94726 <1% 290 $13K
83655 <1% 521 $13K
82950 <1% 407 $12K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 128 $12K
73502 <1% 375 $12K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 79 $12K
77080 <1% 133 $11K
80305 <1% 687 $11K
96361 Intravenous infusion, hydration; each additional hour <1% 226 $11K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 13 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 422 $10K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 32 $10K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 55 $10K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 370 $9K
84403 <1% 111 $9K
J1630 Injection, haloperidol, up to 5 mg <1% 90 $9K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 302 $9K
95819 <1% 69 $8K
99203 Doctor's office visit, new patient (routine) <1% 74 $8K
C1769 Guide wire <1% 63 $8K
S0028 Injection, famotidine, 20 mg <1% 88 $7K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 20 $7K
99153 Mod sedat endo service >5yrs <1% 33 $7K
82105 <1% 139 $7K
84425 <1% 115 $7K
83516 <1% 59 $6K
90686 <1% 332 $6K
88342 <1% 37 $6K
80164 <1% 91 $6K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 129 $6K
92523 <1% 26 $6K
J1245 Injection, dipyridamole, per 10 mg <1% 16 $5K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 45 $5K
90472 Immunization administration, each additional vaccine (list separately) <1% 279 $5K
83013 <1% 25 $5K
83970 <1% 41 $5K
86039 <1% 128 $5K
80074 <1% 39 $4K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 87 $4K
83921 <1% 124 $4K
93225 <1% 72 $4K
86617 <1% 45 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 21 $4K
J0780 Injection, prochlorperazine, up to 10 mg <1% 49 $4K
83540 <1% 131 $4K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 128 $3K
83721 <1% 24 $3K
84132 <1% 130 $3K
76775 <1% 34 $3K
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 13 $3K
93350 <1% 19 $3K
93270 <1% 38 $3K
84207 <1% 56 $3K
90750 <1% 16 $3K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 104 $3K
84156 <1% 101 $3K
76641 <1% 12 $2K
96367 <1% 24 $2K
84146 <1% 26 $2K
71100 <1% 32 $2K
82140 <1% 57 $2K
86666 <1% 13 $2K
82247 <1% 65 $2K
97164 <1% 14 $1K
83090 <1% 54 $1K
93925 <1% 14 $1K
86753 <1% 16 $1K
74018 <1% 31 $993.58
86200 <1% 13 $896.95
82010 <1% 16 $824.48
73140 <1% 12 $812.82
83021 <1% 13 $771.25
80178 <1% 31 $766.51
73080 <1% 15 $702.44
85007 <1% 29 $637.00
90674 <1% 16 $587.10
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 14 $586.00
83014 <1% 25 $553.65
G0499 Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result <1% 17 $538.49
86308 <1% 32 $492.68
86364 <1% 13 $479.50
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 27 $444.63
90662 <1% 17 $424.13
82150 <1% 14 $413.02
86580 <1% 35 $343.11
81005 <1% 26 $332.80
80047 <1% 44 $307.61
Q9957 Injection, perflutren lipid microspheres, per ml <1% 15 $286.48
J3490 Unclassified drugs <1% 701 $200.75
G0008 Administration of influenza virus vaccine <1% 148 $160.96
83986 <1% 17 $95.03
A4649 Surgical supply; miscellaneous 0% 22 $0.00
0250 0% 1,190 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBURKE, JAMES (VP OF FINANCE)
Same official

Other billing entities under BURKE, JAMES

Full network →
ProviderLocationPaid
Affinity Physicians LLC.Warwick, RI$41.76M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.